Since obesity is a main risk factor for type 2 diabetes, hyperaldosteronism in obese patients can contribute to a change in glucose tolerance both by affecting insulin secretion and by changing insulin sensitivity [103]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.